Gilead Sciences | SCHULD



Debt Veränderung Datum
AbbVie USD 69.89B 2.74B 2025-03
Agios Pharmaceuticals USD 48.76M 48.76M 2025-06
ALKERMES USD 72.68M 72.68M 2025-06
Alnylam Pharmaceuticals USD 1.3B 271.5M 2025-06
Amgen USD 56.2B 1.18B 2025-06
Biogen USD 6.59B 296.8M 2025-06
BioMarin Pharmaceutical USD 603.87M 8.22M 2025-06
Bristol-Myers Squibb USD 50.93B 1.22B 2025-06
Eli Lilly USD 39.9B 1.39B 2025-06
Gilead Sciences USD 24.95B 6M 2025-06
GlaxoSmithKline GBP 17.35B 1.08B 2025-06
Glaxosmithkline GBP 16.99B 927M 2024-12
Incyte USD 42.41M 5.29M 2025-06
J&J USD 52.25B 15.62B 2025-03
Merck USD 34.84B 2.27B 2025-03
Moderna USD 741M 4M 2025-06
Neurocrine Biosciences USD 439.1M 8.4M 2025-06
Novartis USD 31.27B 12M 2025-03
Pfizer USD 60.93B 1.18B 2025-06
PTC Therapeutics USD 286.01M 2.12B 2025-06
Regeneron Pharmaceuticals USD 2.71B 300K 2025-06
Sanofi 22.28B 1.24B 2025-06
Sarepta Therapeutics USD 1.35B 215.59M 2025-06
United Therapeutics USD 200M 100M 2025-03
Vertex Pharmaceuticals USD 1.53B 121.7M 2025-06


Gilead Sciences SCHULD - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.